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Reactive oxygen species (ROS)
Mitochondrion
Respiratory chain complexReverse electron transfer (RET) from succinate to NAD+ is known to be accompanied by high generation of
reactive oxygen species (ROS). In contrast, oxidation of fatty acids by mitochondria, despite being a powerful
source of FADH2, does not lead to RET-associated high ROS generation. Here we show that oxidation of
carnitine esters of medium- and long-chain fatty acids by rat heart mitochondria is accompanied by neither
high level of NADH/NAD+ nor intramitochondrial reduction of acetoacetate to β-hydroxybutyrate, com-
parable to those accompanying succinate oxidation, although it produces the same or higher energization of
mitochondria as evidenced by high transmembrane potential. Also in contrast to the oxidation of succinate,
where conversion of the pH difference between the mitochondrial matrix and the medium into the
transmembrane electric potential by addition of nigericin results in a decrease of ROS generation, the same
treatment during oxidation of octanoylcarnitine produces a large increase of ROS. Analysis of respiratory
chain complexes by Blue Native polyacrylamide gel electrophoresis revealed bands that could tentatively
point to supercomplex formation between complexes II and I and complexes II and III. However, no such
association could be found between complex I and the electron transferring ﬂavoprotein that participates in
fatty acid oxidation. It is speculated that structural association between respective respiratory chain
components may facilitate effective reverse electron transfer.ein; FCCP, carbonylcyanide-p-
tron transfer; ROS, reactive
(protonmotive force); ΔΨm,
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Generation of reactive oxygen species (ROS) by respiring isolated
mitochondria [1–4] and by tightly coupled submitochondrial particles
[5] has been known for about four decades. Production of ROS by well
coupled mitochondria with uninhibited respiratory chain oxidizing
NAD-linked substrates is, however, low and can only be increased by
inhibitors blocking the respiratory chain, e.g., antimycin A [6,7], thus
pointing to the high reduction state of certain respiratory chain
carriers as one of the main factors responsible for one-electron re-
duction of molecular oxygen, forming O2•−. In contrast, succinate
oxidation leads to a much higher ROS generation, ﬁrst demonstrated
by Boveris et al. [3]. Later on, it became clear that this was connectedwith the energy-linked reduction of NAD+ by succinate, termed
reverse electron transfer (RET) due to the “uphill” transport of elec-
trons (for early studies see [8–10]). During RET, electrons from
succinate are transferred through complex II of the respiratory chain
to coenzyme Q (ubiquinone) and, under conditions of high electro-
chemical proton gradient (Δp), to complex I and its FMNmoiety, from
which they ﬁnally pass to matrix NAD+. Both succinate-dependent
ROS generation and mitochondrial NAD(P) reduction are sensitive
to uncouplers [11] and inhibitors of the electron transfer within
complex I, like rotenone or amytal [5,10,11]. Similarly, in mito-
chondria that contain high activity of glycerol-3-phosphate dehydro-
genase, a ﬂavoprotein located at the external face of the inner
membrane, e.g., those of insect ﬂight muscles, mammalian skeletal
muscles, mammalian brain and brown adipose tissue, RET can
proceed from glycerol 3-phosphate instead of succinate [12–16].
In terms of the Mitchell's “chemiosmotic” coupling principle [17]
RET can be regarded as an illustration of the reversibility of the
coupling between electron transfer and the mitochondrial membrane
potential. Hence, it is fully understandable that succinate-driven RET
is sensitive to even a small decrease of Δp produced, e.g., by low
concentrations of protonophores or by transition from state 4 to state
3 [3,5,18]. A similar sensitivity has been described for ROS production
that accompanies oxidation of glycerol 3-phosphate [14], thus
pointing to its relation to RET. In contrast to the ROS generation
930 P. Schönfeld et al. / Biochimica et Biophysica Acta 1797 (2010) 929–938linked to the RET from succinate, glycerol 3-phosphate-supported
ROS production is only partly decreased by rotenone [14,19].
We have previously shown [20] that a decrease of succinate-driven
ROS production by long-chain fatty acids is due to their protonophoric
action. In contrast, the ROS production accompanying forward
electron transfer is increased by fatty acids, a phenomenon ascribed
to a partial inhibition of the electron transport by fatty acids [20–22].
The mechanism and site(s) of the superoxide radical (O2•−)
generation within complex I are not fully understood (reviewed in
[23,24]), neither is the ROS generation associated with RET. Fully
reduced FMN, iron–sulphur center(s) (cluster N2) and semi-reduced
coenzyme Q at the Q-binding site of complex I are the most likely
candidates for these sites (reviewed in [23–26]). Recently, an elegant
high resolution X-ray study of the hydrophilic domain of complex I
from Thermus thermophilus has provided a novel insight into the
mechanism of O2•− generation at complex I [27].
It is generally assumed that coenzyme Q, themobile electron carrier
within the inner membrane, links NADH–ubiquinone oxidoreductase
(complex I) not only with succinate–ubiquinone oxidoreductase
(complex II) but also with ﬂavoprotein–ubiquinone oxidoreductase,
mitochondrial ﬂavoprotein glycerol-3-phosphate dehydrogenase, cho-
line dehydrogenase and dihydroorotate dehydrogenase. In the heart,
skeletal muscles and liver, oxidation of activated fatty acids (acyl-CoA)
by the mitochondrial β–oxidation system is the most important
source of FADH2 generation. However, the contribution of fatty acid
oxidation toRET-associatedROSproduction remainsunclear. It has been
claimed that fatty acid oxidation in brain, heart muscle and liver
mitochondria is a potent source of O2•− production by RET [24],
but contrary to this claim studies with isolated mitochondria showed
that L-palmitoylcarnitine as substrate did not promote substantial
ROS production [3,4,16,28,29].
Here we studied ROS generation during fatty acid oxidation by rat
heart and liver mitochondria. Carnitine esters of palmitic, octanoic
and butyric acids were used as examples of activated fatty acids. We
found that ROS production accompanying fatty acid oxidation was
much lower than that with succinate oxidation. However, both
acylcarnitines and succinate produced high quantities of ROS in
respiratory chain-inhibited mitochondria. Despite being a potent
source of FADH2, fatty acid oxidation by mitochondria did not exhibit
RET-associated O2•− generation. Based on Blue Native electrophoresis
of inner membrane proteins, we conﬁrmed supercomplex formation
between complexes I and III and found evidence pointing to a similar
structural link between complexes I and II, but we were unable to
demonstrate association between complex I and electron transferring
ﬂavoprotein (ETF). We speculate that association between individual
components of the respiratory chain may be required not only for the
forward but also for the reverse electron ﬂow.
2. Materials and methods
2.1. Preparation of mitochondria
Heart mitochondria were isolated from adult female Wistar rats
(average weight 150–180 g) by differential centrifugation essentially
as described in [30] using the trypsin-digestion procedure. The
mitochondrial pellet was resuspended in 250 mM sucrose at a con-
centration of 10–12 mg protein/ml. Liver mitochondria were isolated
essentially as described in [31]. Protein content in the stock suspen-
sion was determined by the biuret method using bovine serum
albumin as standard. Functional integrity of mitochondrial prepara-
tions was estimated by the respiratory control ratio, which was
routinely higher than 10 with pyruvate or glutamate (5 mM) plus
malate (5 mM) as substrates. The standard incubation medium was
composed of 110 mM mannitol, 60 mM KCl, 60 mM Tris–HCl, 10 mM
KH2PO4 and 0.5 mM EDTA (pH 7.4). The medium was supplemented
with respiratory substrates as indicated.2.2. Oxygen uptake, determination of acetoacetate and β-hydroxybutyrate,
and ﬂuorimetric measurements
Oxygen uptake by mitochondria was measured using an Oroboros
oxygraph (Bioenergetics and Biomedical Instruments, Innsbruck,
Austria). Acetoacetate and β-hydroxybutyrate were determined
enzymatically [32]. All ﬂuorimetric measurements (see below) were
performed using a Perkin-Elmer LS 50B luminescence spectrometer.
2.3. Measurement of ROS generation
Generation of the superoxide anion radical O2•−was estimated as the
release of H2O2 from mitochondria, monitored ﬂuorimetrically by the
Amplex Red/horseradish peroxidase system, whereby Amplex Red
(non-ﬂuorescent) becomes oxidized to Resoruﬁn (ﬂuorescent). Brieﬂy,
mitochondria (0.2 mgmitochondrial protein per ml) were incubated in
the standard incubationmedium supplementedwith 5 µMAmplex Red
plus horseradish peroxidase (2U/ml). The assay medium was also
supplemented with Cu,Zn-superoxide dismutase (2 U/ml) for quanti-
tative conversion of releasedO2•− into H2O2. Resoruﬁn ﬂuorescencewas
monitored at 560 nmand590 nmexcitation and emissionwavelengths,
respectively. It was calibrated by additions of known quantities of H2O2.
Addition of acylcarnitines at the concentrations used had no effect on
the calibration curve.
Release of the superoxide anion radical into the matrix compartment
was estimated by measuring the degree of inactivation of mitochondrial
aconitase [33]. This was measured by recording the rate of NADP+
reduction similarly as described in [34]. Brieﬂy, after the experiment the
medium was supplemented with 5 mM citrate, 0.8 mM NADP+, 0.6 mM
MnCl2 and isocitrate dehydrogenase (2 U/ml) followed by 0.05% (v/v)
lauroyl maltoside to enable the access of the reagents to the matrix
compartment. The rate of NADPH formation was recorded spectropho-
tometrically at 340 nm and 37 °C for 10 min.
2.4. Mitochondrial membrane potential
Alteration in the mitochondrial transmembrane potential (ΔΨm)
was evaluated from the uptake or release of safranine O [35] moni-
tored ﬂuorimetrically as ﬂuorescence quenching measured at 495 nm
(excitation) and 586 nm (emission) wavelengths [36].
NAD(P)H ﬂuorescence was measured at 358 nm excitation and
465 nmemissionwavelengths. Full oxidation of endogenous NAD(P)H
was achieved by substrate-free incubation of mitochondria for at least
5 min.Maximal reductionwas achieved by addition of 5 mM succinate
followed by 5 mM KCN.
2.5. High resolution Blue Native (BN) and SDS polyacrylamide gel (PAGE)
two-dimensional separation of mitochondrial proteins
This was carried out essentially as described in [37]. In brief,
mitochondria were solubilized in 1.5 M aminocaproic acid, 50 mM bis-
Tris–HCl (pH 7.0) and digitonin used at the amount of 3 mg/mg
mitochondrial protein. Samples were incubated on ice for 20–30 min
and centrifuged at 20,000×g for 15 min to remove unsolubilized
material. Samples of the supernatant containing 60 µg of mitochondrial
protein eachwere combinedwith 1 µl of 5% Coomassie brilliant blue and
separatedona large (1 mm×16 cm×20 cm)5–12%gradientacrylamide
gel in theﬁrst dimension. Localizationof complexes andsupercomplexes
in slices of theﬁrstdimensiongelwasperformedby identifyingpositions
of complexes V (ATPase), I and II using in-gel activity assays, and by
immunoblotting of the second dimension of BN-PAGE with antibodies
against subunits of individual respiratory chain complexes.
2.5.1. In-gel activity assay
To visualize activities of monomeric, dimeric andmultimeric forms
of mitochondrial ATPase (complex V), the gel was incubated at 35 °C
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MgSO4, 0.2% Pb(NO3)2 and 8 mM ATP (pH 7.8). The incubation was
terminated when white bands characteristic for the active forms ofFig. 1. ROS release by rat heart mitochondria (RHM) and rat liver mitochondria (RLM) o
protonophore. Succinate (Succ) was used at a ﬁnal concentration of 5 mM; ﬁnal concen
concentration of palmitoylcarnitine (PalC) was 20 nmol/mg protein; malate (Mal) concentr
0.5 µM. ROS released as H2O2 was measured by the Amplex Red/horseradish peroxidase p
respect to incubations without inhibitors or uncoupler.complex V became visible (about 12 h). To visualize complex I
activity, the gel was incubated at 35 °C with 3 mM Tris–HCl (pH 7.4)
containing 60 µM NADH and 245 µM nitrotetrazolium blue (NBT). Toxidizing succinate or acylcarnitine esters; effects of respiratory chain inhibitors and
trations of octanoylcarnitine (OctC) and butyrylcarnitine (ButC) were 0.5 mM; ﬁnal
ation was 0.1 mM. Rotenone (Rot) was 5 µM, antimycin A (AA) was 5 µM and FCCP was
rocedure. Data (means±SD) are for 5–10 mitochondrial preparations; * pb0.05 with
Fig. 2. ROS production by rat heart mitochondria assessed by aconitase inactivation.
Mitochondria (0.2 mg protein/ml) were incubated in EDTA-free incubation medium
supplemented with 5 mM succinate or 0.5 mM octanoylcarnitine plus 0.1 mM malate.
Rotenone (5 µM), antimycin A (5 µM) and FCCP (0.5 µM) were present where
indicated. After 15 min incubation aconitase activity was measured in solubilized
material as described under Section 2. Abbreviations as in Fig. 1. Data (means±SD) are
for 4 mitochondrial preparations; * pb0.05 with respect to substrate-free incubation
(none).
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phosphate buffer (pH 7.4), 5 mM EDTA, 10 mM KCN, 50 mM
succinate, 0.2 mM phenazine methosulphate and 245 µM NBT. The
incubations for complexes I and II were terminated when bands
characteristic for each complex became visible (about 5 h).
2.5.2. Second dimension SDS PAGE–Western blot
Lanes of the ﬁrst dimension gel were separated and incubated in a
dissociating solution (1% SDS and 1% 2-mercaptoethanol) for 30 min
at room temperature. Then, they were washed in the electrophoresis
buffer, stacked over a 10% SDS polyacrylamide gel and separated at a
constant current of 35 mA until the front of the blue dye reached the
end of the gel. Proteins were transferred onto a PVDFmembrane using
standard procedure. The membranes were immunoblotted with
antibodies against subunits of individual respiratory chain complexes
(1:5000) and ETF (1:1000).
2.6. Chemicals and antibodies
ADP, digitonin, succinate, rotenone, antimycin A, nigericin, carbo-
nylcyanide-p-triﬂuoromethoxyphenylhydrazone (FCCP), acetoace-
tate, β-hydroxybutyrate dehydrogenase, Cu,Zn-superoxide
dismutase, horseradish peroxidase (Type VI-A), lauroyl maltoside
and isocitrate dehydrogenasewere from Sigma-Aldrich Chemie GmbH
(Sternheim, Germany). Amplex Red was obtained from Invitrogen
(Eugene, OR, USA). L-Palmitoylcarnitine, L-octanoylcarnitine and L-
butyrylcarnitinewere from Larodan Fine Chemicals (Malmö, Sweden).
Antibodies against complexes of oxidative phosphorylation (mono-
clonal, OXPHOS cocktail kit) were from MitoSciences (Eugene, OR,
USA) and that against ETF (rabbit, polyclonal 73986-200) was from
Abcam (Cambridge, UK).
2.7. Statistical analysis
Values are expressed as means±SD. Statistical signiﬁcance was
determined by the Student's t-test. Probability (p) values less than
0.05 were considered signiﬁcant.
3. Results
3.1. ROS release
The rate of ROS release from heart mitochondria oxidizing car-
nitine esters of long- and medium-chain fatty acids was much lower
than that in the presence of succinate (Fig. 1A, B, C and D) and
comparable to that with NAD-linked substrates, pyruvate or gluta-
mate (not shown). An increase of acylcarnitine concentration from
0.5 mM up to 5 mM (examined with butyryl- and octanoylcarnitine)
did not enhance ROS production (not shown). It was unchanged or
only slightly increased by a complex I inhibitor, rotenone, but strongly
enhanced when antimycin A, a complex III inhibitor, was also added
(Fig. 1 B, C and D). In contrast, ROS generation with succinate as the
sole substrate was strongly inhibited by rotenone and was partly, but
not fully, restored by a subsequent addition of antimycin A (Fig. 1 A).
At these conditions, electrons from the acyl-CoA dehydrogenase
reaction (the ﬁrst reaction of β-oxidation) could only pass to complex
III. Thus, the high ROS production in the presence of acylcarnitines by
mitochondria inhibited with rotenone plus antimycin A points to the
high capacity of β-oxidation to generate FADH2.
The ROS generation associated with succinate oxidation in the
absence of respiratory chain inhibitors is very sensitive to depolar-
ization of the inner membrane. Thus, ROS release was strongly
decreased by the protonophoric uncoupler FCCP (Fig. 1 A). With
acylcarnitines as respiratory substrates this decrease was less
pronounced (Fig. 1 B, C and D).In liver mitochondria the succinate-driven ROS release was
several-fold lower than in rat heart mitochondria. Similarly, the
respiratory chain inhibitors induced smaller changes (Fig. 1 E, F andG).
The superoxide generated by complex I is released to the matrix
side of the inner membrane [28,38], whereas that generated at
complex III is supposed to partition approximately equally between
the inner and the outer sides of the inner membrane [39]. Hence, the
Amplex Red/horseradish peroxidase system is unable directly to
measure the total ROS production. Therefore, ROS generationwas also
assessed by inactivation of the matrix enzyme aconitase, a hydro-
xyacid dehydratase that is particularly sensitive to O2•− [33]. It was
found that aconitase activity of heart mitochondria oxidizing succi-
nate in the presence of rotenone remained high (reﬂecting low
intramitochondrial ROS production), whereas rotenone plus anti-
mycin A resulted in a strong inactivation of aconitase (Fig. 2A). Thus,
this indirect method of estimation of ROS production inside mito-
chondria supports the results of direct measurements of ROS release
to the external medium with the use of Amplex Red plus horseradish
peroxidase (Fig. 1 A). With octanoylcarnitine, aconitase activity was
higher than with succinate (Fig. 2 A und B), indicating a lower ROS
concentration in the matrix. Moreover, in mitochondria oxidizing
octanoylcarnitine addition of rotenone resulted in a decrease of
aconitase activity (indicating increased ROS generation), in contrast
to its effect in mitochondria oxidizing succinate. In conclusion, both
the release of H2O2 to the external medium and the O2•− formation
and release into the matrix indicate opposite responses of ROS
generation in mitochondria oxidizing succinate and those oxidizing
octanoylcarnitine.
3.2. Mitochondrial respiration and membrane polarization
RET is particularly sensitive to the electrochemical proton gradient
(Δp) at themitochondrial membrane and so is the RET-associated ROS
production (for recent reviews see [24,25]). Therefore, it was of
primary interest to see whether carnitine esters of fatty acids were
able to generate Δp comparable to that produced by succinate. For
that purpose, ΔΨm as the major component of Δp was recorded in
mitochondria oxidizing succinate, palmitoylcarnitine and octanoyl-
carnitine using safranine O ﬂuorescence. It was found that all three
substrates generated high ΔΨm, as shown by a similar ﬂuorescence
Fig. 3. Membrane potential and respiration rates of mitochondria oxidizing acylcarnitines and/or succinate. Rat heart mitochondria (RHM, 1 mg protein) were added to 1.0 ml
incubation medium supplemented with succinate (5 mM) or octanoylcarnitine (0.5 mM) plus malate (0.1 mM) or palmitoylcarnitine (20 nmol per mg protein) plus malate
(0.1 mM). Abbreviations as in Fig. 1. A. Membrane potential measured with 5 µM safranine O. Decrease of safranine O ﬂuorescence (downward deﬂection) indicates increase of ΔΨ.
Final concentration of FCCPwas 0.5 µM. B. Respiration rates. Active state (state 3) respirationwas obtained by adding ADP to ﬁnal concentration of 2 mM. Data (means±SD) are for 5
mitochondrial preparations.
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parable ﬂuorescence increases produced by the protonophore FCCP.
Moreover, addition of palmitoylcarnitine or octanoylcarnitine to
mitochondria already respiring with succinate usually produced a
further small increase of ΔΨ (Fig. 3, panel A).Fig. 4. Redox state of nicotinamide nucleotides in mitochondria oxidizing acylcarnitines or s
free incubationmedium. Concentrations of added substrates were as described in the legend
is taken as 100%. Abbreviations as in Fig. 1.We also compared the oxidation rates of octanoylcarnitine and
succinate. In the resting state (state 4), respiration of heart mitochondria
oxidizing octanoylcarnitine was half that supported by succinate
oxidation, whereas the rate of respiration in the active state (state 3)
was up to 3 times higher than that with succinate (Fig. 3, panel B).uccinate. Rat heart mitochondria (1 mg protein) were suspended in 1.0 ml of substrate-
to Fig. 3. NAD(P) reduction in the presence of succinate following addition of 1 mM KCN
Fig. 5. Reduction of acetoacetate by mitochondria oxidizing succinate or octanoylcar-
nitine. Rat heart mitochondrial (2.5 mg protein) were added to incubation medium
(1.0 ml) containing: (a) 0.7 mM acetoacetate (Acac); (b) 5 mM succinate+0.7 mM
acetoacetate (Succ/Acac); (c) 0.5 mM octanoylcarnitine (OctC); and (d) 0.5 mM
octanoylcarnitine+0.7 mM acetoacetate (OctC/Acac). Samples were incubated for
30 min at 37 °C. The reaction was stopped by centrifugation and supernatant was
rapidly frozen in liquid air. Acetoacetate and β-hydroxybutyrate were determined
enzymatically. Data shown are means±SD for 3 or 4 experiments.
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the mitochondrial membrane nor the activity of ETF dehydrogenase
are likely to be limiting factors for RET and the accompanying ROS
generation in the course of fatty acid oxidation.
3.3. Reverse electron transfer
Despite strongly energizing heart mitochondria, carnitine esters
produced a much lower reduction of nicotinamide nucleotides thanFig. 6. Effect of phosphate and nigericin on membrane potential of mitochondria respiring w
suspended in 1.0 ml of incubation medium supplemented with 5 mM succinate (A) or 0.5 m
were added to ﬁnal concentrations of 1 mM or 10 mM phosphate (Pi) and 0.1 µM nigeric
safranine O as in Fig. 3.did succinate. In the presence of submillimolar concentration of
malate (0.1 mM), palmitoylcarnitine and octanoylcarnitine reduced
about 50% of endogenous mitochondrial NAD(P), whereas succinate
produced a practically complete reduction (Fig. 4). In these experi-
ments the reduction obtained with succinate followed by subsequent
addition of cyanide was taken as 100%.
A further argument in this line was provided by measurements of
reduction of added acetoacetate to β-hydroxybutyrate, a reaction
catalyzed by intramitochondrial β-hydroxybutyrate dehydrogenase
and utilizing intramitochondrially generated NADH. As shown in
Fig. 5, acetoacetate added to the incubation medium was almost
quantitatively reduced to β-hydroxybutyrate in the presence of
succinate, whereas it remained in its (native) oxidized form when
mitochondria were respiring with octanoylcarnitine. Oxidation of
octanoylcarnitine alone produced only negligible amounts of
acetoacetate.
3.4. Effect of matrix pH on ROS release
Oliveira and Kowaltowski [40] have demonstrated that accumu-
lation of phosphate ions in the mitochondrial matrix induces an
increased H2O2 efﬂux. On the other hand, it has also been reported
[41–43] that a decrease of matrix pH induced by either phosphate or
nigericin (a H+/K+ exchanger) signiﬁcantly decreases succinate-
supported ROS production. This effect has been attributed to desta-
bilization of the semiquinone radical by making the matrix compart-
ment less alkaline [43]. These observations prompted us to investigate
the effects of various concentrations of medium phosphate and of an
addition of nigericin on ROS release from heart mitochondria
oxidizing succinate or acylcarnitines.
Since ΔpH can be converted into ΔΨm in energized mitochondria,
we ﬁrst demonstrated that, indeed, increasing concentrations of
phosphate or nigericin increased the ΔΨm, independently of whether
the mitochondria were respiring with succinate or octanoylcarnitineith succinate (A) or octanoylcarnitine (B). Rat heart mitochondria (1 mg protein) were
M octanoylcarnitine+0.1 mMmalate (B). Aliquots of 1 M phosphate or 10 µM nigericin
in (Nig), as indicated. Mitochondrial membrane potential was monitored with 5 µM
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convert ΔpH into ΔΨm, a process that was completed only after
addition of nigericin. Parallel measurements of ROS release showed
that, in the presence of succinate as respiratory substrate, both phos-
phate and nigericin resulted in a decrease of ROS release (Fig. 7 A) in
agreement with earlier observations [41,43]. In contrast, with
octanoylcarnitine, nigericin produced a large increase of ROS release
(Fig. 7 B). Interpretation of these results is not straightforward, since
phosphate had either no effect or even slightly decreased the ROS
release with octanoylcarnitine. Nevertheless, the effect of nigericin in
the presence of octanoylcarnitine was opposite to that in the presence
of succinate, thus conﬁrming that the mechanisms of ROS release or
production are different with these two substrates.
3.5. Formation of supercomplexes
To investigated whether the RET from succinate to complex I and
further on to NAD+ could be facilitated by a structural connection
between individual complexes, a search for possible interactions
between the respiratory chain complexes was performed using two-
dimensional Blue Native electrophoresis of mitochondrial proteins.
Coomassie blue staining of the 1st dimension gel showed a number
of bands corresponding to all ﬁve complexes and their knownmulti-
complex structures. The identiﬁcation of individual complexes
(Fig. 8 A, upper strip) was based on in-gel activity assays of mito-
chondrial ATPase (complex V) and complexes I and II as described
under Section 2. Fig. 8 B compares the localisation of in-gel activityFig. 7. Effect of phosphate and nigericin on ROS release. Rat heart mitochondria (RHM,
0.2 mg or 0.4 mg protein) were added to 1.0 ml of incubation medium supplemented
with 5 mM succinate (A) or 0.5 mM octanoylcarnitine+0.1 mMmalate. Phosphate and
nigericin were added to obtain their ﬁnal concentrations of 1 mM or 10 mM phosphate
and 0.1 µM nigericin as in Fig. 6. The numbers at traces indicate H2O2 release expressed
in pmol/min per mg protein. ROS release was measured by Amplex Red/horseradish
peroxidase procedure.bands of complex I (strip b) and complex II (strip d) with the local-
isation of ETF determined by immunoblotting (strip c). An in-gel
activity assay for complex II (strip d) reveals three bands that
could be identiﬁed as complex II alone (1) and putative super-
complexes [II+III] (2) and [II+I] (3). However, no band indicating
co-localisation of complex I with ETF could be detected in strip b.
4. Discussion
To our knowledge, the present paper is the ﬁrst to demonstrate
that RET does not accompany mitochondrial fatty acid oxidation.
Although oxidation of fatty acids, feeding electrons to both complex III
(through acyl-CoA dehydrogenase, electron transferring ﬂavoprotein:
ubiquinone oxidoreductase and coenzyme Q) and complex I (through
β-hydroxyacyl-CoA dehydrogenase and NADH) [17], could theoreti-
cally induce reverse electron ﬂow by the former pathway, no such
process seems to occur, at least in rat heart mitochondria nor, most
likely, in rat liver mitochondria. Thus, in contrast to high ROS gen-
eration during succinate oxidation-associated RET, rat heart mito-
chondria oxidizing acylcarnitines of short-, medium- and long-chain
fatty acids release only low amounts of ROS in the resting state. This
was found by both direct measuring of H2O2 release to the medium
(Fig. 1) and by indirect assessment of intramitochondrial ROS produc-
tion by measuring the degree of aconitase inactivation (Fig. 2). In
addition, a low degree of reduction of the mitochondrial NAD(P) pool
(Fig. 4) and the failure to reduce externally added acetoacetate (Fig. 5)
were observed with acylcarnitines, both in contrast to high reduction
by succinate.
The RET related to succinate oxidation is known to be accompa-
nied by high ROS production [2] (for review and more references see
also [25]). Similarly, elevated ROS generation associated with RET
during oxidation of glycerol 3-phosphate has been reported for insect
ﬂight muscle mitochondria [14] and mammalian brain mitochondria
[15] (but not so much for brown adipose tissue mitochondria [19]).
The apparent absence of RET accompanying fatty acid oxidation is
also conﬁrmed by no or low sensitivity of this ROS production to
uncoupling, in contrast to high inhibition of succinate-associated ROS
generation (Fig. 1). Moreover, the ROS production accompanying
oxidation of fatty acids was increased by rotenone and even more so
by rotenone plus antimycin A, whereas that accompanying oxidation
of succinate was strongly inhibited by rotenone (Fig. 1), in accordance
with the known inhibition of RET by the latter poison. The low ROS
production by fatty acid oxidation found in the present study is in full
agreement with earlier observations by Tahara et al. [16].
A difference between the mechanisms of ROS generation during
fatty acid oxidation and succinate oxidation is also illustrated by
the effect of nigericin thereupon. Nigericin, an H+/K+ exchanger,
equilibrates intramitochondrial and external pH in high potassium
media and induces a conversion of ΔpH into ΔΨm (Fig. 6). Such
treatment was found to decrease ROS generation accompanying suc-
cinate oxidation (Fig. 6 A), conﬁrming previous observations by other
authors [41,43], the effect attributed to destabilization of the
semiquinone radical by making the matrix compartment less alkaline
[43]. In contrast, nigericin strongly increased ROS production
accompanying fatty acid oxidation (Fig. 7 B).
The lack of fatty acid-associated RET is not due to insufﬁcient
energization of mitochondria. As shown by direct measurements,
ΔΨm generated by oxidation of octanoylcarnitine or palmitoylcarni-
tine was similar to or even slightly higher than that generated by
succinate oxidation (Fig. 3). Moreover, it is unlikely that the RET from
fatty acid oxidation could be limited by the efﬁciency of respective
dehydrogenases, since active state oxidation of octanoylcarnitine
appeared even higher than that of succinate (Fig. 3). Then, the
question arises as to the factors responsible for the absence of fatty
acid-associated RET and accompanying ROS generation. The following
explanations can be considered.
Fig. 8. Blue Native (BN) and SDS polyacrylamide gel electrophoresis (PAGE) of rat heart mitochondrial proteins; search for supercomplex formation. (A) Two-dimensional BN-PAGE.
Identiﬁcation of individual protein bands was carried out by immunoblotting of respiratory chain complexes and in-gel activity assay for mitochondrial ATPase (complex V). Upper
strip shows positions of OXPHOS complexes and their associations. Arrows to the right point to individual subunits. (B) In-gel activity assays for complex I (strip b) and complex II
(strip d), and immunoblot for ETF (strip c). Strip a is the same as in panel A. Arrows at the bottom point to: (1) a broad band of complex II (succinate dehydrogenase), (2) putative
association of complexes II and III, and (3) putative association of complexes I and II.
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it has been proposed that a high RET-associated O2•− production could
be attributed to fully reduced ﬂavin (FMNH2) as set by a high NADH/
NAD+ ratio [44]. Thus, the lack of RET-associated O2•− production
during fatty acid oxidation could be due to the lower reduction of the
NAD(P) pool compared with that attained with succinate (Fig. 4).
However, when the rates of ROS production by mitochondria with
inhibited complex I and under succinate-driven RET were compared,
no unique relationship between O2•− production and the NADH/NAD
+ ratio was found [45]. For example, rotenone-treated mitochondria
oxidizing pyruvate plus malate released less O2•− than those oxidizing
succinate, despite the NAD(P) pool under the former conditions being
more reduced. Therefore, it seems likely that RET-associated O2•−
is mainly formed from semi-reduced coenzyme Q at the coenzyme
Q-binding site of complex I and full reduction of FMN is not oblig-
atory, a view proposed by Selivanov et al. [43].
Second, in contrast to succinate, oxidation of acylcarnitines pro-
duces NADH that provides electrons passing down the respiratory
chain and FADH2 that can push electrons up the respiratory chain to
complex I. This raises the question of whether NADH oxidation by
complex I may partly inhibit RET-associated O2•− production. This has
been studied with mitochondria from skeletal muscle [46] and brain
[47], showing that simultaneous oxidation of succinate and NAD-
dependent substrates results, unexpectedly, in a higher O2•− produc-
tion than with succinate alone. This is explained by inhibition of
succinate dehydrogenase within complex II by oxaloacetate (whensuccinate is the sole substrate), which is abrogated during simulta-
neous oxidation of succinate and glutamate/pyruvate.
Third, according to the classical concept of the electron transport
chain [17], respiratory complexes I, II and III form separate entities
within the inner mitochondrial membrane, functionally linked by
coenzyme Q freely diffusing in the lipid phase of the membrane and
transferring electrons from the reduced to the oxidized forms of the
complexes. According to this concept, RET within complex I should
proceed independently of the source of reduced coenzyme Q, i.e.,
whether it comes from complex I, ETF or glycerol-3-phosphate dehy-
drogenase, provided sufﬁcient energization of the mitochondrial
membrane makes such a process thermodynamically possible. In
contrast to this classical view, our present understanding of the elec-
tron transport chain assumes the existence of structural connections
between individual complexes resulting in the formation of super-
complexes ([48,49], for recent reviews see also [50,51]). Moreover,
according to this view mitochondrial coenzyme Q does not form a
common pool but, at least in part, is more or less tightly bound to
individual complexes [50,52,53]. This view is also compatible with the
proposal of Vinogradov et al. [54] that the forward electron transfer
and the RET proceed by two different routes within complex I.
It has been hypothesized [55] that supercomplex formation mini-
mizes the “electron leak” and ROS generation by facilitating electron
transfer along the respiratory chain. This supramolecular arrange-
ment of the respiratory chain may help to explain the efﬁcient opera-
tion of the forward electron ﬂow from complex I through complex III
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control analysis [56]. In contrast, it is claimed that no such channelling
or association exists between complexes II and III and between
complexes I and II [48,50,56] (but also see opposite opinions [53,55]).
If so, the electron ﬂow between these complexes should be mediated
by collisional interactions in the coenzyme Q pool. This may apply to
both forward and reverse electron ﬂows. The present results seem,
however, to point to possible structural links between complexes I
and II and complexes II and III, as indicated by respective bands on
Blue Native PAGE (Fig. 8 B). It has to be stressed, however, that the
presence of in-gel activity bands of succinate dehydrogenase (the
main component of complex II) at bands corresponding to expected
localisation of complexes I and III does not necessarily mean for-
mation of respective supercomplexes, as it might be due to association
with other proteins of similar electrophoretic mobility. A more
detailed study would therefore be needed to conﬁrm formation of
such supercomplexes. Although the suggestion for supercomplexes
[I–II] and [II–III] should be regarded as preliminary and requires a
more rigorous documentation, also by functional analyses, it could
help to explain the occurrence of RET from succinate to NAD+.
Interestingly, it has been proposed recently [57] that succinate may
speciﬁcally promote an interaction between complex II and complex I.
In contrast, no such common band could be found for complex I and
ETF (Fig. 8 B, compare strips c and d). One could, however, argue that
ETF, a soluble protein, is not likely to form stable association with
respiratory chain complexes and that ETF dehydrogenase would be a
better candidate to form such supramolecular structure. Therefore,
explanation of the lack of RET from ETF to NAD+ and of the absence of
RET-associated ROS generation during fatty acid oxidation requires
further investigation.
In conclusion, the present investigation shows that oxidation of
fatty acids in heart and (possibly) liver mitochondria, in contrast to
oxidation of succinate, does not produce a substantial reverse electron
transfer and, consequently, the accompanying increased ROS gener-
ation. This difference is unlikely to be due to differences in the
thermodynamics or kinetics of both processes. A plausible explana-
tion could be offered by putative differences in the supramolecular
organization of respective segments of the respiratory chain. Since
RET is associated with elevated ROS generation, the lack of RET during
fatty acid oxidation minimizes the risk of oxidative stress and mito-
chondrial damage by ROS. This is an important factor, since fatty acids
are common respiratory substrates for many kinds of cells. In contrast,
succinate is an intermediate of the tricarboxylic acid cycle and its
steady state concentration under normal conditions is low. In addi-
tion, succinate dehydrogenase is controlled in a subtle way by its
potent inhibitor oxaloacetate that is also another intermediate of
the tricarboxylic acid cycle [46,47]. Therefore, elevated ROS genera-
tion accompanying succinate oxidation is not likely to produce a
major oxidative stress to mitochondria under normal metabolic
conditions.
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